These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11055757)

  • 1. Twenty-year trend of chronic excretors of tubercle bacilli based on the nationwide tuberculosis prevalence surveys in Korea, 1975-1995.
    Hong YP; Kim SJ; Bai JY; Lew WJ; Lee EG
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):911-9. PubMed ID: 11055757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The seventh nationwide tuberculosis prevalence survey in Korea, 1995.
    Hong YP; Kim SJ; Lew WJ; Lee EK; Han YC
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):27-36. PubMed ID: 9562108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004.
    Bai GH; Park YK; Choi YW; Bai JI; Kim HJ; Chang CL; Lee JK; Kim SJ
    Int J Tuberc Lung Dis; 2007 May; 11(5):571-6. PubMed ID: 17439684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cohort analyses of the treatment of smear-positive pulmonary tuberculosis patients under programme conditions in Korea, 1983-1994.
    Hong YP; Kim SJ; Lew WJ; Lee SH; Lee EK
    Int J Tuberc Lung Dis; 1998 May; 2(5):365-71. PubMed ID: 9613631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment monitoring and prevalence of drug resistance in tuberculosis patients in Tehran.
    Bahrmand AR; Velayati AA; Bakayev VV
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):544-9. PubMed ID: 10864185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003.
    Munsiff SS; Li J; Cook SV; Piatek A; Laraque F; Ebrahimzadeh A; Fujiwara PI
    Clin Infect Dis; 2006 Jun; 42(12):1702-10. PubMed ID: 16705575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prevalence and risk factors of drug-resistant tuberculosis among migratory population in Shanghai, China].
    Shen X; Shen M; Gui XH; Gao Q; Mei J
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):407-10. PubMed ID: 17673008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiologic study of the actual investigation of chronic excretors of Mycobacterium tuberculosis bacilli].
    Tsuchiya T; Kondo A; Sakatani M
    Kekkaku; 1996 Jan; 71(1):31-6. PubMed ID: 8808266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary drug resistance in Mycobacterium tuberculosis among patients with pulmonary tuberculosis and its impact on permanent disability in the Volgograd region].
    Borzenko AS; gagarina SG; Samoĭlova IV; Kalushenina AA
    Probl Tuberk Bolezn Legk; 2007; (12):28-30. PubMed ID: 18326212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
    Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan, 1997.
    Abe C; Hirano K; Wada M; Aoyagi T
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):46-52. PubMed ID: 11263516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to anti-tuberculosis drugs and practices in drug susceptibility testing in Moldova, 1995-1999.
    Crudu V; Arnadottir T; Laticevschi D
    Int J Tuberc Lung Dis; 2003 Apr; 7(4):336-42. PubMed ID: 12729338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
    Al-Rubaish AM; Madania AA; Al-Muhanna FA
    Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of directly-observed treatment on the epidemiology of tuberculosis in Beijing.
    Zhang LX; Tu DH; Enarson DA
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):904-10. PubMed ID: 11055756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis drug resistance and treatment outcomes under DOTS settings in large cities in the Philippines.
    Ohkado A; Aguiman L; Adlawan S; Baring E; Quirante O; Suchi M; Endo S; Fujiki A; Mori T
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):283-9. PubMed ID: 16562708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
    Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sixth Nationwide Tuberculosis Prevalence Survey in Korea, 1990.
    Hong YP; Kim SJ; Kwon DW; Chang SC; Lew WJ; Han YC
    Tuber Lung Dis; 1993 Oct; 74(5):323-31. PubMed ID: 8292205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.